Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis.

Martin ŠubertMichal NovotnýTereza TykalováBarbora SrpováLucie FriedováTomáš UherDana HorákováJan Rusz

Published in: Therapeutic advances in neurological disorders (2023)

Automated discourse analysis has the potential to provide an easy-to-implement and low-cost language-based biomarker of cognitive decline in MS for future clinical trials.

Keyphrases

cognitive decline
multiple sclerosis
low cost
mild cognitive impairment
clinical trial
deep learning
machine learning
autism spectrum disorder
high throughput
traumatic brain injury
mass spectrometry
white matter
current status
randomized controlled trial
phase ii
open label
climate change
data analysis